SCHEMBL6311562

SCHEMBL6311562

CCCCCCCCCCc1c(C)c(C#N)c2nc3ccccn3c2c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.43
MAPT P10636 5/20 0.43
NPSR1 Q6W5P4 4/20 0.43
KMT2A Q03164 4/20 0.43
HTT P42858 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
RAB9A P51151 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.39
KDM4E B2RXH2 6/20 0.37
GRK6 P43250 1/20 0.36
ALDH1A1 P00352 5/20 0.36
LMNA P02545 4/20 0.36
GAA P10253 2/20 0.36
APAF1 O14727 2/20 0.36
NOD2 Q9HC29 1/20 0.36
SLC2A1 P11166 1/20 0.36
CASP1 P29466 3/20 0.36
CASP7 P55210 3/20 0.36
HSD17B10 Q99714 3/20 0.36
SAE1 Q9UBE0 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6310742 1.00 HPGD (0.43) HPGDMAPTNPSR1KMT2AHTT
SCHEMBL6312086 0.96 MAPT (0.47) HPGDMAPTNPSR1KMT2AHTT
SCHEMBL6310328 0.88 NPSR1 (0.44) HPGDMAPTNPSR1KMT2AHTT
SCHEMBL6311004 0.83 ENPP2 (0.43) HPGDMAPTNPSR1SMN1; SMN2RAB9A
SCHEMBL6310471 0.82 HSD17B10 (0.39) HPGDMAPTNPSR1KMT2AHTT
SCHEMBL6312786 0.81 KDM4E (0.44) HPGDMAPTNPSR1KMT2AHTT
SCHEMBL6311028 0.81 L3MBTL1 (0.38) HPGDMAPTNPSR1KMT2AHTT
SCHEMBL6311689 0.81 ALDH1A1 (0.40) HPGDMAPTNPSR1KMT2ASMN1; SMN2
SCHEMBL6318124 0.80 ALDH1A1 (0.43) HPGDMAPTNPSR1KMT2ASMN1; SMN2
SCHEMBL6310816 0.80 HPGD (0.46) HPGDMAPTNPSR1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 HPGD 2061/4885MAPT 1694/4885NPSR1 1531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.